ABM Indus (NYSE:ABM) Stock

ABM Indus

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

Upgrades

Small Cap

Analyst Ratings

The year 2024 was an extremely fruitful one for investors, with the S&amp;P 500 Index soaring in excess of 20%. Adding to the optimism, data pertaining to manufacturing activity was impressive in January. The Institute of Supply Management&#39;s survey, released earlier this month, showed that its manufacturing PMI jumped to 50.9 in January, the highest reading since September 2022.

5 Broker-Loved Stocks To Keep An Eye On After Recent Analyst Upgrades


Shares of ABM Industries (NYSE:ABM) fell more than 7% after its FQ4 release, opening an attractive entry for dividend growth investors. This Dividend King fell to a critical support level near the middle of its

ABM Industries Stock: A Dividend King at a Discount

ABM Industries Inc

ALBIOMA by Albioma

ABCOURT MINES INC B by Abcourt Mines Inc.

Abcourt Mines Inc

AMER BIO MEDICA CORP by American Bio Medica Corp.

American Bio Medica Corp

American Battery Technology Co

PRODIGY GOLD NL by Prodigy Gold NL

ABN AMRO Bank NV

ADVANCED BIOMEDICAL TECHS by Advanced BioMedical Technologies, Inc.

Advanced BioMedical Technologies Inc

The year 2024 was an extremely fruitful one for investors, with the S&amp;P 500 Index soaring in excess of 20%. Adding to the optimism, data pertaining to manufacturing activity was impressive in January. The Institute of Supply Management&#39;s survey, released earlier this month, showed that its manufacturing PMI jumped to 50.9 in January, the highest reading since September 2022. The significant decline in inflation followed by the Fed&#39;s rate cuts has gone a long way in boosting the demand scenario. Donald Trump&#39;s return as President has also added to the optimism.
Given this encouraging backdrop, investors would do well to keep a tab on broker-friendly stocks like Dana DAN, Camping World CWH, ABM Industries ABM, Cardinal Health CAH and DXC Technology DXC.
We have designed a screen to shortlist stocks based on improving broker recommendations and upward revisions in earnings estimates over the past four weeks. Also, since the price/sales ratio is a strong complementary valuation metric in the presence of broker information, it has been included. The price/sales ratio takes care of the company&#39;s top line, making the strategy a well-rounded one.
<h2>Screening Criteria</h2>
# (Up- Down Rating)/ Total (4 weeks) =Top #75&nbsp;(This gives the list of the top 75 companies that have witnessed net upgrades over the last 4 weeks).
% change in Q (1) est. (4 weeks) = Top #10&nbsp;(This gives the top 10 stocks that have witnessed earnings estimate revisions over the past 4 weeks for the upcoming quarter).
Price-to-Sales = Bot%10&nbsp;(The lower the ratio, the better. Companies meeting this criterion are in the bottom 10% of our universe of over 7,700 stocks with respect to this ratio).
Price greater than 5&nbsp;(as a stock trading below $5 will not likely create significant interest for most of the investors).
Average Daily Volume greater than 100,000 shares over the last 20 trading days&nbsp;(Volume has to be significant to ensure that these are easily traded).
Market value ($ mil) = Top #3000&nbsp;(This gives us stocks that are the top 3000 in terms of market capitalization).
Com/ADR/Canadian= Com&nbsp;(This takes out the ADR and Canadian stocks).
Here are five of the 10 stocks that made it through the screen:
Dana&nbsp;is a provider of power conveyance and energy-management solutions for vehicles and machinery in North America, Europe, South America and the Asia Pacific. The company is headquartered in Maumee, OH.
DAN currently sports a Zacks Rank #1 (Strong Buy). The Zacks Consensus Estimate for DAN&#39;s 2025 earnings has been revised 15.4% upward over the past 60 days.
You can see&nbsp;<a href="https://www.zacks.com/stocks/buy-list/?ADID=zp_1link&amp;ICID=zpi%20_1link" target="_blank">the complete list of today&#39;s Zacks #1 Rank stocks here</a>
Camping World Holdings, currently carrying a Zacks Rank #2 (Buy), retails recreational vehicles and related products and services in the United States. It operates through two segments, Good Sam Services and Plans and RV and Outdoor Retail.
The company aims to capitalize on the current favorable environment for dealership mergers and acquisitions. CWH outpaced the Zacks Consensus Estimate for earnings in two of the last four quarters and missed the mark in the other two. The average beat was 16.6%.
New York-based&nbsp;ABM Industries&nbsp;is a provider of integrated facility solutions in the United States and other countries. ABM currently carries a Zacks Rank #2. The company has an impressive surprise history, with its earnings surpassing the Zacks Consensus Estimate in each of the last four quarters, the average beat being 11.6%.
ABM launched ELEVATE in 2021. It is designed to drive organic growth and modernize its digital ecosystem. The acquisition of RavenVolt in 2022 strengthened the company&#39;s presence in EV infrastructure and power solutions.
Cardinal Health is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. CAH has two reporting segments &mdash; Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution and Others.
Cardinal Health has an expected earnings growth rate of 5.3% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 1.4% over the last 60 days. CAH currently carries a Zacks Rank #2.&nbsp;
DXC Technology&nbsp;is benefiting from strength in the digital business and partnerships, which are helping it expand in the cloud computing space. DXC is implementing robust cost-saving measures to enhance its financial performance.
Over the past 60 days, the Zacks Consensus Estimate for DXC Technology&#39;s current-year earnings has increased 5.4%. DXC&#39;s earnings surpassed estimates in the last four quarters, the average beat being 22.2%. The company currently carries a Zacks Rank #3 (Hold).
You can get the rest of the stocks on this list by signing up now for a 2-week free trial to the Research Wizard stock picking and backtesting software. You can also create your own strategies and test them first before making investments.
The Research Wizard is a great place to begin. It&#39;s easy to use. Everything is in plain language. And it&#39;s very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
<a href="https://woas.zacks.com/zcom/researchwizard/tools3.php?site=ZCOM_RW_IND_ARTICLES">Click here to sign up for a free trial to the Research Wizard today</a>.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks&#39; portfolios and strategies are available at:&nbsp;<a href="https://www.zacks.com/performance">https://www.zacks.com/performance</a>
&nbsp;
<h2>Only $1 to See All Zacks&#39; Buys and Sells</h2>
We&#39;re not kidding.
Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.
Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like&nbsp;Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.
<a href="https://www.zacks.com/registration/ultimatetrader/welcome/eoffer/6328?adid=SYND_BENZ_ZU_ZU_ANALYSTBLOG_259_IND_02182025_2417283&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283" style="font-weight:bold">See Stocks Now &gt;&gt;</a>
&nbsp;
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. <a href="https://www.zacks.com/registration/pfp/?ALERT=RPT_7BST_LP194&amp;ADID=SYND_BENZ_7BEST_ANALYSTBLOG_259_2417283&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283" target="_blank">Click to get this free report</a>

&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=CAH&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_CAH&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">Cardinal Health, Inc. (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/cah#NYSE">CAH</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=ABM&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_ABM&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">ABM Industries Incorporated (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=DAN&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_DAN&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">Dana Incorporated (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/dan#NYSE">DAN</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=CWH&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_CWH&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">Camping World (NYSE: </a><a class="ticker" href="https://www.benzinga.com/stock/cwh#NYSE">CWH</a>): Free Stock Analysis Report 
&nbsp; 
<a href="https://www.zacks.com/registration/pfp?ALERT=ZER_LINK&amp;t=DXC&amp;ADID=SYND_BENZ_TCK_ANALYSTBLOG_259_2417283_DXC&amp;cid=CS-BENZ-FT-analyst_blog|rw-2417283">DXC Technology Company. (DXC): Free Stock Analysis Report</a>
<a href="https://www.zacks.com/stock/news/2417283/5-broker-loved-stocks-to-keep-an-eye-on-after-recent-analyst-upgrades?cid=CS-BENZ-FT-analyst_blog|rw-2417283">To read this article on Zacks.com click here.</a>
<a href="https://www.zacks.com/">Zacks Investment Research</a>

UBS analyst Joshua Chan maintains ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) with a Neutral and raises the price target from $55 to $56.

News

Price Target

UBS Maintains Neutral on ABM Indus, Raises Price Target to $56

<h3>Gainers</h3>
<ul>
<li>Vast Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTE#NASDAQ">VSTE</a>) stock moved upwards by 83.1% to $2.38 during Wednesday's pre-market session. The market value of their outstanding shares is at $71.3 million. </li>
<li>1847 Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#AMEX">EFSH</a>) stock moved upwards by 32.81% to $0.3. The market value of their outstanding shares is at $4.8 million. </li>
<li>Richtech Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RR#NASDAQ">RR</a>) shares rose 21.91% to $1.5. The market value of their outstanding shares is at $142.1 million. </li>
<li>Ming Shing Group Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSW#NASDAQ">MSW</a>) shares moved upwards by 17.68% to $5.79. The market value of their outstanding shares is at $75.1 million. </li>
<li>Hyzon Motors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYZN#NASDAQ">HYZN</a>) shares rose 13.07% to $1.9. The company's market cap stands at $14.4 million. </li>
<li>Greenwave Tech Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) stock increased by 12.58% to $0.72. The market value of their outstanding shares is at $16.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Silynxcom (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SYNX#AMEX">SYNX</a>) stock declined by 16.6% to $3.31 during Wednesday's pre-market session. The market value of their outstanding shares is at $17.4 million. </li>
<li>Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) stock decreased by 11.79% to $4.94. The market value of their outstanding shares is at $42.9 million. </li>
<li>HUHUTECH International Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUHU#NASDAQ">HUHU</a>) stock declined by 10.63% to $4.22. The market value of their outstanding shares is at $89.2 million. </li>
<li>Toro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTC#NYSE">TTC</a>) stock fell 9.49% to $77.22. The market value of their outstanding shares is at $8.0 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Mesa Air Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESA#NASDAQ">MESA</a>) shares decreased by 9.17% to $1.09. The market value of their outstanding shares is at $45.0 million. </li>
<li>ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) stock declined by 8.58% to $50.2. The market value of their outstanding shares is at $3.1 billion. The company's, Q4 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

EFSH

GWAV

HUHU

HYZN

MESA

SIDU

SYNX

VSTE

12 Industrials Stocks Moving In Wednesday's Pre-Market Session

ABM Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) shares are trading lower after the company reported<a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/g42549751/abm-reports-fourth-quarter-and-full-fiscal-2024-results-and-provides-fiscal-2025-outlook" rel="noreferrer noopener"> fourth-quarter FY24&nbsp;earnings</a>.
Sales grew&nbsp;4.0%&nbsp;year over year to&nbsp;$2.18 billion, beating the consensus of&nbsp;$2.079 billion. Revenue growth was driven by Technical Solutions (+35%&nbsp;Y/Y) and Aviation (+11%), with Education revenue being flat Y/Y.
Operating expenses increased&nbsp;5.4% to&nbsp;$1.91 billion, and operating profit declined&nbsp;81.9%&nbsp;to&nbsp;$19.2 million&nbsp;in the quarter.
Adjusted EBITDA fell 11%&nbsp;to&nbsp;$128.0&nbsp;million, with the margin stood at&nbsp;6.1% vs. 7.2% a year ago quarter. Adjusted EPS of&nbsp;$0.90, down 11%&nbsp;Y/Y, beating&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">the consensus of&nbsp;$0.87</a>.
Operating cash flow for the quarter totaled&nbsp;$30.3&nbsp;million, down from&nbsp;$139.1 million a year ago. As of October-end, ABM held cash and equivalents of&nbsp;$64.6 million.
ABM declared a cash dividend of&nbsp;$0.265&nbsp;per common share, payable on February 3, 2025, to shareholders of record on January 2, 2025. As previously announced, the dividend&nbsp;represents a&nbsp;17.8%&nbsp;increase over the <a target="_blank" href="https://www.benzinga.com//node/42350771" rel="noreferrer noopener">prior quarterly cash dividend.</a>
Scott Salmirs, President &amp; Chief Executive Officer, said, &#8220;The significant growth of our microgrid service line and the market gains we made in Aviation were critical to overcoming challenges in other parts of the business. These results support our diversification strategy.&#8221;
&#8221;While it is still early and the macro environment is unclear following the recent election, recent data points suggest our key commercial real estate markets are nearing an inflection to growth. Additionally, other parts of our business are continuing to experience generally healthy market conditions.&#8221;
2025 Outlook: ABM expects FY25 adjusted EPS&nbsp;of&nbsp;$3.60 &#8211; $3.80&nbsp;vs.&nbsp;consensus of $3.66&nbsp;and <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">adjusted EBITDA margin of&nbsp;6.3%-&nbsp;6.5%</a>.
The company expects revenue, margin, and earnings growth in 2025, citing the positive backdrop.
Price Action: ABM shares are down 8.58% at $50.20&nbsp; at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42554393" target="_blank" rel="noreferrer noopener">Disney&#8217;s Marvel Rivals Game Hits 20 Million Players, Proves Superhero Power Still Reigns</a></li>
</ul>

Earnings

Equities

Mid Cap

ABM Industries Stumbles Despite Q4 Earnings Beat - What's Going On?

Guidance

ABM Sees FY25 Adjusted EPS Outlook Of $3.60-$3.80 Vs. $3.66 Est., Adjusted EBITDA Margin Of 6.3% to 6.5%

ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) reported quarterly earnings of $0.90 per share which beat the analyst consensus estimate of $0.87 by 3.45 percent. The company reported quarterly sales of $2.177 billion which beat the analyst consensus estimate of $2.079 billion by 4.71 percent. This is a 4.03 percent increase over sales of $2.093 billion the same period last year.

Earnings Beats

ABM Indus Q4 2024 Adj. EPS $0.90 Beats $0.87 Estimate, Sales $2.177B Beat $2.079B Estimate

<h3>Companies Reporting Before The Bell</h3>
• SPDR Bloomberg Convertible Securities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWB#NYSE">CWB</a>) is projected to report quarterly earnings at $0.88 per share on revenue of $304.67 million. 
• Tokyo Lifestyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKLF#NASDAQ">TKLF</a>) is likely to report earnings for its first quarter. 
• OrganiGram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $43.78 million. 
• Jabil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) is estimated to report quarterly earnings at $1.83 per share on revenue of $6.61 billion. 
• General Mills (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>) is projected to report quarterly earnings at $1.22 per share on revenue of $5.13 billion. 
• ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) is estimated to report quarterly earnings at $0.87 per share on revenue of $2.07 billion. 
• Birkenstock Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $439.27 million. 
• Toro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTC#NYSE">TTC</a>) is projected to report quarterly earnings at $1.05 per share on revenue of $1.11 billion. 
<h3>Companies Reporting After The Bell</h3>
• cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $4.81 million. 
• Lennar (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) is projected to report quarterly earnings at $4.26 per share on revenue of $10.08 billion. 
• Enerpac Tool Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAC#NYSE">EPAC</a>) is expected to report quarterly earnings at $0.47 per share on revenue of $150.00 million. 
• Worthington Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WS#NYSE">WS</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $724.35 million. 
• Steelcase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCS#NYSE">SCS</a>) is likely to report quarterly earnings at $0.23 per share on revenue of $812.02 million. 
• Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) is likely to report quarterly earnings at $1.76 per share on revenue of $8.55 billion. 
• MillerKnoll (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) is projected to report quarterly earnings at $0.53 per share on revenue of $959.70 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIRK

Spdr Barclays Capital Convertible Securities Etf

EPAC

MLKN

TKLF

YCBD

Earnings Scheduled For December 18, 2024

ABM Industries Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) will release earnings results for its fourth quarter, before the <a href="https://www.benzinga.com/quote/ABM/earnings">opening bell on Wednesday, Dec. 18.</a>
Analysts expect the New York-based company to report quarterly earnings at 87 cents per share, down from $1.01 per share in the year-ago period. ABM Industries projects to report revenue of $2.08 billion for the recent quarter, compared to $2.09 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 5, ABM raised its quarterly dividend from 22.5 cents to 26.5 cents per share.
ABM shares gained 1.1% to close at $56.76 on Monday.
Benzinga readers can access the latest analyst ratings on the<a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie"> Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/ABM/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>UBS analyst Joshua Chan maintained a Neutral rating and raised the price target from $51 to $55 on Sept. 9. This analyst has an accuracy rate of 71%.</li>
<li>Truist Securities analyst Jasper Bibb maintained a Hold rating and increased the price target from $49 to $55 on Sept. 9. This analyst has an accuracy rate of 77%.</li>
<li>Baird analyst Andrew Wittmann maintained a Neutral rating and increased the price target from $49 to $56 on Sept. 9. This analyst has an accuracy rate of 81%.</li>
</ul>
Considering buying ABM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="456" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17023225/image-136-1024x456.png" alt="" class="wp-image-695245" style="width:635px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17023225/image-136-1024x456.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17023225/image-136-300x134.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17023225/image-136-768x342.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/17023225/image-136.png 1447w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42509800/wall-streets-most-accurate-analysts-give-their-take-on-3-financial-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields</a></li>
</ul>

Markets

Trading Ideas

ABM Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Dividends

ABM Increases Quarterly Dividend From $0.225 To $0.265

<a href="https://www.globenewswire.com/Tracker?data=dDt0M3F1yrxUZhKJuN9jE3I0EZP6iMCtbu_r8oP0QvcTAM4t8ORGDnIKlLeTq2unqUOoUgtXb-9nAnI8D1msOg==">ABM (NYSE:</a><a href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>), a leading provider of integrated facility services, infrastructure solutions, and parking management today announced a strategic partnership with <a href="https://www.globenewswire.com/Tracker?data=IdQ6h-8JPvpeYyPhMgh6axiAEL-6JlfN4eYNthQaCSMQN-X2tAIE34R3GTfDP1dpXVN7ZWge1gcU-6YHIEZaTmkeuu1waU9nxqjiL2rLhsQ=">Mainspring Energy, Inc</a>., in which ABM will deploy Mainspring's cutting-edge Linear Generator technology to enhance electric vehicle ("EV") charging solutions for fleet, commercial and industrial clients that require turnkey offerings and on-site power generation projects.
The availability and reliability of the power needed to support commercial fleets is often a main obstacle for commercial fleet operators seeking to deploy electrification strategies. Mainspring's state-of-the-art Linear Generators provide efficient, on-site power by converting linear motion into electricity. The differentiated fuel-flexible generators can also directly run on highly sustainable renewable and zero-carbon fuels such as biogas, hydrogen, and ammonia, as well as traditional fuels like natural gas and propane, providing clients with important flexibility.
The technology's ability to be quickly deployed at scale is particularly appealing to large fleet operators seeking to quickly and cost-effectively deploy resilient EV charging infrastructure while reducing emissions and working toward net-zero goals.

ABM Announces A Strategic Partnership With Mainspring Energy, In Which ABM Will Deploy Mainspring's Linear Generator Technology To Enhance EV Charging Solutions For Fleet, Commercial And Industrial Clients That Require Turnkey Offerings And On-site Power Generation Projects

<a href="https://www.globenewswire.com/Tracker?data=u__EcdHyxyoNqn01p2yG1vMlvN47sF2FkFGe-sdX9GqR7I8HbDcDvEmZIPlZ_Yn7tZ_u1HkDpxUgsHgDNw1rAA==">ABM (NYSE:</a><a href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>), a leading provider of integrated facility services, infrastructure solutions, and parking management, today announced a distributorship agreement with <a href="https://www.globenewswire.com/Tracker?data=6xDlfYiK6RHtxZ1B-aj2ncXx1sxHNVHZ23D8Jn-FH-DacqXwzc2NmQpLGqLUrmu579-M9-ewGQne0QCgid1glNP6MsNZVVW4WVYDCHLE154=">Samsung C&amp;T</a> Charging Solutions, making ABM an authorized distributor and servicer of EVSIS-branded DC Fast Chargers. Samsung C&amp;T Charging Solutions is an equity partner of the Korean DC Fast Chargers manufacturer EVSIS, which is entering the United States market. &nbsp;
The EVSIS chargers are versatile and high-quality, with best-in-class technology that integrates seamlessly with the cloud-based <a href="https://www.globenewswire.com/Tracker?data=3c82g6zuJHtSlAHprFkNAjBjCYt4m5ugaDVEOVcjLBVGGtXdtXbKN6PSQ4TiIUyBdFMVw9x56CoPQqtRjRUAKqPsYPA9-GcgvqBAg1U9nPthwR9LjjsCsSJBg959koScU7oe-2KGY5oqZMnC1Uz5TYgdBXupjsqJNA735KYBiZHgs8yPctcL0MeitK3PEKsTO_vCxScGVvr1Q1PFuoaF0iHFUJwUjGX3u_EkgihogBxHnqjEywISQD2bnXgqzSvz0G3rT_IQdZUhMe-GA8Ce17UE5ttef9FVGvhiodgkpUBff-2OOtbhOEl9ceGNmMo58EaHEBBQRmerk_yLD9fSjFZ4pxTvB5AKdTBcbqz7MZZnMHMRNIQ43EmEh1eYKI0Isdp8A7k_IJiSU_BJGBCiI_t_0TfM6S1_X2aNHctrDOgro76lkXPT31tsJY1C4kjqG2R8UT3NtxMlke190kGPGFCP5DcqAA6RndYJmFzjAoeAN2Cb11pcq_PBpDJpKjiEJzwayugvIqKALSnJmxxGt3VlHs1HPC1kDc-n022mlpPz22CAKJypZIMvWFI_1Mg6sgrmgDrlzLjwAmk7AxQO1h5QZtK3pFGCJ4Hu_3AMtDyQDttkFPb7m3dy1l_Mr6mFxCVjq8ipJQcT7FGm4N_v84nC7WOreAwkazTulVdnMAgZLoPUqHwqp0ZyuMTfJG8DPGkIP2KVT6AI2OnUXnq6K0q5n-0NKitWaXP0_GmHnBREYeuE19LbJTfVKELSl1xz_4LXljkXpixEzPGnFAMjAJK4KmW2HMKpC5qZba28AO6004-TyTVx8QQMsXfEDPWIUXlzjfmsdmmuKb-wwB4_jZPUAMSQhECTNd6JAhZpHWW8ZRhQ7uyn_rft56grwjI-2jCXDWfItZ-DFdsu6dh6risAwVOVDF89u2GcC7jcIbxKZNlpVdmEmnq5Kca4hbSMwQGdBPM5jPbpIOb-28flmk2PVYoEPl2mz4Z4qnnM6AVppBeA8Xgx8LuzEGpOmHGBX1zeiy5lHdkQjGIIVAlbAW-AuFOmQjgEtwgRFbgnOGcgVmQdlcz1sYT-YjQnuP_qAQ2Nshrdbw9B3zyzDxenKk2vbnO-9Qqyx0VkdoW6ddwWkGPmOPlgmsQuzhs5wJ4a">ABM EV OS</a> platform – enabling for scalable expansion, intelligent monitoring, remote operation management, comprehensive reporting, and automatic infrastructure diagnostics. Through this partnership, all EVSIS chargers will be offered and serviced alongside ABM's current charger portfolio.

SSNLF

ABM Expands Charger Portfolio With Samsung C&T Charging Solutions Partnership

GE HealthCare Technologies&#39; (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gehc#NASDAQ">GEHC</a>) MIM Software recently announced the receipt of FDA clearance for performing Centiloid scaling for positron emission tomography (PET)-based amyloid imaging analysis and quantification.
With MIMneuro, a vendor-neutral solution, this new Centiloid scale tool is likely to be able to assist physicians in more accurately determining the density of amyloid plaque in a patient&#39;s brain. Amyloid PET radiotracers help visualize amyloid plaque density in patients being evaluated for Alzheimer&#39;s disease.
<h2>Likely Trend of GEHC Stock Following the News</h2>
Following the announcement, shares of the company moved nearly 1.7% north to $88.53 at yesterday&#39;s close.
GE HealthCare is one of the leading providers of medical technology, pharmaceutical diagnostics, and digital solutions with a focus on precision care. In March, GE Healthcare acquired MIM Software, which added AI-based solutions for the practice of radiation oncology, molecular radiotherapy, diagnostic imaging, and urology at imaging centers, hospitals, specialty clinics and research organizations worldwide. Owing to the strong potential for the diagnostic imaging market, we expect the market sentiment to remain positive around this news.
Meanwhile, GEHC currently has a market capitalization of $39.63 billion. It has an earnings yield of 4.91% is much higher than the industry&#39;s yield of negative (7.12)%. In the last reported quarter, GEHC delivered an earnings surprise of 2.04%.
<h2>More on the GEHC&#39;s Centiloid Scaling Tool</h2>
A significant number of people in the United States develop dementia, with Alzheimer&#39;s disease accounting for 60-80% of dementia cases. The condition affects memory, thinking and behavior, and symptoms typically start with mild cognitive impairment and eventually grow severe enough to interfere with daily tasks. A characteristic feature of this condition is the build-up of beta-amyloid protein in the brain, which is connected to tissue loss and cell death.
In order to assist physicians in identifying potential patients for amyloid-targeting therapies, PET imaging makes it possible to visualize and quantify amyloid protein. A global consortium of physicians and scientists created the Centiloid scale with the goal of harmonizing quantitative amyloid imaging analysis throughout radiotracers and organizations.
GE HealthCare&#39;s MIM Software now offers MIMneuro with Centiloid scaling, leveraging an automated workflow to help guide users through generating and understanding the quantitative result. The software takes the PET amyloid images, provides clinicians instructions to automatically generate quantitative results, and presents the data in a standardized report for clinicians to review alongside the images. As a result, clinicians can more easily access the quantitative data they need to evaluate patients.
MIMneuro with Centiloid scaling is the latest addition to GE HealthCare&#39;s comprehensive suite of products and solutions, which span the Alzheimer&#39;s disease care pathway from diagnosis through treatment monitoring.
<h2>Favorable Industry Prospects for GEHC</h2>
Per a report by Future Market Insight, the global brain imaging and neuroimaging market was estimated to be $13.7 billion in 2023 and is anticipated to surpass $22.4 billion by 2033 at a CAGR of 5.1%. The brain imaging and neuroimaging market is primarily driven by the rising incidence and prevalence of neurological disorders, increased awareness of neurodegenerative diseases, an increase in traumatic brain injuries, and increased applications of brain imaging and neuroimaging in clinical trials.
Given the market potential, the latest FDA clearance of MIM Software&#39;s Centiloid Scaling Tool is likely to provide a boost to GEHC&#39;s business.
<h2>GEHC&#39;s Notable Developments</h2>
In August, GEHC announced the receipt of the CE mark for its Vscan Air SL wireless handheld ultrasound system with Caption AI. The company also received the CE mark for the use of ECG-less cardiac computed tomography scanning on its Revolution Apex platform.
The company also collaborated with the University of California San Diego School of Medicine. The tie-up aims to investigate advanced magnetic resonance imaging protocols and techniques for female-specific diseases and conditions of the pelvis and develop comprehensive educational materials for clinicians.
<h2>GEHC&#39;s Price Performance</h2>
In the past six months, GEHC shares have lost 2.6% compared with the industry&#39;s decline of 12.4%. The S&amp;P 500 has gained 7.6% in the same time frame.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/51/78442.jpg?v=1728486434" />
Image Source: Zacks Investment Research
<h2>GE HealthCare&#39;s Zacks Rank &amp; Stocks to Consider</h2>
GEHC carries a Zacks Rank #3 (Hold) at present.
Some better-ranked stocks in the broader medical space are&nbsp;Universal Health Service&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uhs#NYSE">UHS</a>),&nbsp;Quest Diagnostics&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dgx#NYSE">DGX</a>) and&nbsp;ABM Industries&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>). While Universal Health Service sports a Zacks Rank #1 (Strong Buy), Quest Diagnostics and ABM Industries carry a Zacks Rank #2 (Buy).
Universal Health Service has an estimated long-term growth rate of 19%. UHS&#39; earnings surpassed estimates in each of the trailing four quarters, with the average being 14.58%.
Universal Health Service has gained 56.1% so far this year compared with the&nbsp;industry&#39;s&nbsp;48.1% rise.
Quest Diagnostics has an estimated long-term growth rate of 6.20%. DGX&#39;s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 3.31%.
Quest Diagnostics shares have gained 13.9% so far this year compared with the&nbsp;industry&#39;s&nbsp;17.9% rise.
ABM Industries&#39; earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 7.34%.
ABM&#39;s shares have risen 27.4% so far this year compared with the&nbsp;industry&#39;s&nbsp;17% growth.
<a href="https://www.zacks.com/stock/news/2338704/gehc-stock-rises-as-fda-clears-mim-software-s-centiloid-tool?cid=CS-BENZ-FT-analyst_blog|company_news_medical_sector-2338704">To read this article on Zacks.com click here.</a>

Biotech

Large Cap

General

GEHC

GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool

Solventum Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/solv#NYSE">SOLV</a>) recently announced the launch of the V.A.C. Peel and Place Dressing, an integrated dressing and drape that can be applied quickly&nbsp;and worn by patients for up to seven days.
Traditional dressings for negative pressure wound therapy typically take more than twice as long to apply, require a multi-step process of measuring and cutting separate foam and adhesive components, and may need to be changed at least three times a week.
The latest launch by SOLV is likely to solve the persisting issues of traditional dressings for negative pressure wound therapy, making it more accessible and less painful. The V.A.C. Peel and Place Dressing is an essential innovation in wound care that has the potential to improve outcomes, save both time and money and enhance the overall patient and clinician experience.
Due to the factors mentioned above, the product is likely to witness substantial demand in the field of negative pressure wound therapy and contribute to the top-line growth of the company, thus driving the share price of SOLV higher.
<h2>More on the SOLV&#39;s V.A.C Peel and Place Dressing</h2>
The latest development in V.A.C.&nbsp;Therapy is the new V.A.C.&nbsp;Peel and Place Dressing. Due to its integrated dressing and drape design, dressing application and changes are easier to perform, requiring less time and training. Moreover, it has an integrated non-adherent, perforated layer that reduces tissue ingrowth and lessens discomfort when removing the dressing.
The V.A.C. Peel and Place Dressing is suggested for use on wounds up to 6 cm deep, covering chronic, acute, traumatic, subacute, and dehisced wounds. Additionally, it can be used on partial thickness burns, pressure ulcers (such as those caused by diabetes), venous insufficiency, flaps, and grafts.
Research has demonstrated that the V.A.C. Peel and Place Dressing can substantially reduce&nbsp;therapy application time. It can also lower hospital bedside expenditures significantly&nbsp;because of fewer dressing changes and lower&nbsp;home nursing visits per week.
V.A.C.&nbsp;Therapy has been linked to noticeably faster wound healing. Over nearly three decades, it has been used globally to treat more than 10 million wounds. However, a rise in wound numbers is increasing due to aging populations and the incidence of chronic illnesses such as obesity and diabetes. The V.A.C. Peel and Place Dressing enables V.A.C. Therapy to be used on a wider range of patients across the continuum of care in both acute and post-acute settings.
The product is available now in the United States and Canada. Additional global regulatory submissions and approvals are pending.
<h2>Favorable Industry Prospects for SOLV</h2>
Per a report by Grand View Research, the global negative pressure wound therapy market size was estimated to be $2.5 billion in 2023 and is expected to witness a CAGR of 6.6% from 2024 to 2030.
Given the market potential, SOLV&#39;s V.A.C Peel and Place Dressing is likely to provide a boost to SOLV&#39;s business.
<h2>SOLV&#39;s&nbsp;Price Performance</h2>
In the past six months, SOLV shares have lost 1.1% compared with the industry&#39;s decline of 1.3%. The S&amp;P 500 has gained 6.4% in the same time frame.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/9f/77363.jpg?v=2024522534" />
Image Source: Zacks Investment Research
<h2>SOLV&#39;s Zacks Rank and Stocks to Consider</h2>
Currently, SOLV has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader medical space are&nbsp;Universal Health Service&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uhs#NYSE">UHS</a>),&nbsp;Quest Diagnostics&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dgx#NYSE">DGX</a>)&nbsp;and&nbsp;ABM Industries&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>). While Universal Health Service sports a Zacks Rank #1 (Strong Buy), Quest Diagnostics and ABM Industries presently carry a Zacks Rank #2 (Buy).
Universal Health Service has an estimated long-term growth rate of 19%. UHS&#39; earnings surpassed estimates in each of the trailing four quarters, with the average being 14.58%.
Universal Health Service has gained 56.1% so far this year compared with the&nbsp;industry&#39;s&nbsp;48.1% rise.
Quest Diagnostics has an estimated long-term growth rate of 6.20%. DGX&#39;s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 3.31%.
Quest Diagnostics shares have gained 13.9% so far this year compared with the&nbsp;industry&#39;s&nbsp;17.9% rise.
ABM Industries&#39; earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 7.34%.
ABM&#39;s shares have risen 27.4% so far this year compared with the&nbsp;industry&#39;s&nbsp;17% growth.
<a href="https://www.zacks.com/stock/news/2334834/solventum-shares-may-gain-on-the-launch-of-its-new-v-a-c-therapy?cid=CS-BENZ-FT-analyst_blog|company_news_medical_sector-2334834">To read this article on Zacks.com click here.</a>

Health Care

Events

SOLV

Solventum Shares May Gain on the Launch of Its New V.A.C Therapy

UBS analyst Joshua Chan maintains ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) with a Neutral and raises the price target from $51 to $55.

UBS Maintains Neutral on ABM Indus, Raises Price Target to $55

Truist Securities analyst Jasper Bibb maintains ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) with a Hold and raises the price target from $49 to $55.

Truist Securities Maintains Hold on ABM Indus, Raises Price Target to $55

Baird analyst Andrew Wittmann maintains ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) with a Neutral and raises the price target from $49 to $56.

Baird Maintains Neutral on ABM Indus, Raises Price Target to $56

WIIM

ABM Industries shares are trading lower. The stock gained after the company reported better-than-expected Q3 financial results and raised its FY24 adjusted EPS guidance above estimates but has since reversed.

ABM Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) shares are trading higher after the company reported&nbsp;third-quarter&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g40746750/abm-reports-third-quarter-fiscal-2024-results-and-raises-outlook-for-fiscal-year-2024-adjusted-eps" rel="noreferrer noopener">earnings and raised&nbsp;guidance</a>.
Sales grew 3.3% Y/Y to $2.09 billion, beating the consensus of $2.037 billion. Revenue growth was driven by Technical Solutions (+25% Y/Y) and Aviation (+13%), with Education increasing by 4% Y/Y.
Operating expenses increased&nbsp;3.7%&nbsp;Y/Y to&nbsp;$1.83 billion, and operating profit declined&nbsp;73.1% Y/Y to&nbsp;$37.4 million in the quarter.
Adjusted EBITDA rose 2% Y/Y to $128.1 million, with the margin remaining flat Y/Y at 6.4%. Adjusted EPS of $0.94, up 19% Y/Y, beating <a href="https://www.benzinga.com/earnings" target="_blank" rel="noreferrer noopener">the consensus of $0.86</a>.
Operating cash flow for the quarter totaled&nbsp;$79.5 million, down from&nbsp;$149.1 million&nbsp;a year ago. As of July-end, ABM held cash and equivalents of&nbsp;$86.3 million.
Dividend:&nbsp;ABM declared a cash dividend of&nbsp;$0.225&nbsp;per common share, payable on November 4, 2024, to shareholders of record on October 3, 2024.
Scott Salmirs, President &amp; Chief Executive Officer, said, &#8220;Our investments in the energy resiliency markets, particularly in microgrids, which grew significantly, as well as those investments in technology, including tools that improve labor efficiency and our go-to-market approach, helped us deliver another quarter of solid organic growth on an enterprise level and resilient margins.&#8221;&nbsp;
&#8220;This performance was supported by our focus on market segmentation, especially our purposeful weighting towards higher performing Class A properties, which enabled us to once again perform well in our Business &amp; Industry segment, despite a still choppy commercial real estate environment.&#8221;
2024&nbsp;Outlook: ABM raised the adjusted EPS outlook to&nbsp;$3.48 &#8211; $3.55 (from $3.40 &#8211; $3.50)<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> versus the&nbsp;$3.47&nbsp;consensus</a>.
Price Action: ABM shares are up 6.95%&nbsp;at&nbsp;$60.00 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40746080/us-stocks-set-for-steep-fall-amid-heightened-anxiety-ahead-jobs-data-vix-surges-strategist-flags-2-" target="_blank" rel="noreferrer noopener">US Stocks Set For Steep Fall Amid Heightened Anxiety Ahead Jobs Data, VIX Surges: Strategist Flags 2 Reasons Why He Expects More Volatility Ahead</a></li>
</ul>

ABM Industries Delivers Solid Q3 Results On Investment In Energy Market, Boosts Guidance

ABM Industries shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY24 adjusted EPS guidance above estimates.

ABM Raises FY24 Adjusted EPS Outlook To $3.48-$3.55 (From $3.40-$3.50 ) Vs. $3.47 Est.

Press Releases

ABM to Announce Third Quarter 2024 Financial Results

ABM Reports Third Quarter Fiscal 2024 Results and Raises Outlook for Fiscal Year 2024 Adjusted EPS

Contracts

ABM Expands Charger Portfolio with Samsung C&T Charging Solutions Partnership

UGI Corporation Appoints Melanie Ruiz and David Bingenheimer to its Board of Directors

Management

ABM Announces Appointment of New General Counsel

ABM and Mainspring Energy Sign Strategic Partnership

ABM to Announce Fourth Quarter and Full Year 2024 Financial Results

ABM Increases Dividend 18%

ABM Reports Fourth Quarter and Full Fiscal 2024 Results and Provides Fiscal 2025 Outlook

ABM Launches New Brand Platform Reinforcing Transformation as an Innovative and Tech-Enabled Solutions Provider

Ambipar Emergency Response Class A Ordinary Shares

Ambipar Emergency

Mobile Infrastructure Corporation Common Stock

Mobile Infrastructure

BrightView Hldgs

CECO Environmental

Clean Harbors

Casella Waste Systems, Inc. - Class A Common Stock

Casella Waste Sys

Decent Holding

ESGL Holdings Limited - Class A Ordinary Shares

ESGL Holdings

Fuel Tech

Li-Cycle Holdings

LanzaTech Global

Montrose Environmental Group, Inc. Common Stock

Montrose Environmental Gr

Enviri

Perma-Fix Environmental Services, Inc. - Common Stock

Perma-Fix Envirn Servs

Primech Holdings

Quest Resource Holding Corporation - Common Stock

Quest Resource Holding

Rollins

Republic Servs

Rentokil Initial plc American Depositary Shares (each representing five (5) Ordinary Shares)

Comments

ABM Indus

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga